Kidney biomarkers such as NGAL, KIM-1, IL-18, L-FABP (liver-type fatty acid–binding protein), and CysC possess the capacity to fill several knowledge gaps about AKI, including early detection, differential diagnosis, and prognosis. Here, FABP1 is linked to acute kidney injury.